Evidence map›Paper›PMID 30364136›Full record

ReviewFrontiers in neurology2018

Detection Methods for Autoantibodies in Suspected Autoimmune Encephalitis.

Gerda Ricken, Carmen Schwaiger, Desiree De Simoni, Valerie Pichler, Julia Lang, Sarah Glatter, Stefan Macher, Paulus S Rommer, Petra Scholze, Helmut Kubista and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. High-grade gliomas with autoimmune encephalitis-like presentation: case report and systematic review of the literature.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. The role of autoantibodies in Alzheimer's disease: Pathogenetic connections or epiphenomena?Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Cell-based vs enzyme-linked immunosorbent assay for detection of anti-Tribbles homolog 2 autoantibodies in Chinese patients with narcolepsy.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Gerda RickenInstitute of Neurology, Medical University of Vienna, Vienna, Austria.
Carmen SchwaigerInstitute of Neurology, Medical University of Vienna, Vienna, Austria.
Desiree De SimoniInstitute of Neurology, Medical University of Vienna, Vienna, Austria.
Valerie PichlerInstitute of Neurology, Medical University of Vienna, Vienna, Austria.
Julia LangInstitute of Neurology, Medical University of Vienna, Vienna, Austria.
Sarah GlatterInstitute of Neurology, Medical University of Vienna, Vienna, Austria.
Stefan MacherDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Paulus S RommerDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Petra ScholzeDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Helmut KubistaCenter for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Inga KonecznyInstitute of Neurology, Medical University of Vienna, Vienna, Austria.
Romana HöftbergerInstitute of Neurology, Medical University of Vienna, Vienna, Austria.
Medical University of Vienna · AT

Funding

Austrian Science Fund FWF I 3334Austrian Science Fund FWF J 3545Austrian Science Fund FWF T 996
6 · The paper itself

Abstract

This review provides an overview on different antibody test methods that can be applied in cases of suspected paraneoplastic neurological syndromes (PNS) and anti-neuronal autoimmune encephalitis (AIE) in order to explain their diagnostic value, describe potential pitfalls and limitations, and discuss novel approaches aimed at discovering further autoantibodies. Onconeuronal antibodies are well-established biomarkers for PNS and may serve as specific tumor markers. The recommended procedure to detect onconeuronal antibodies is a combination of indirect immunohistochemistry on fixed rodent cerebellum and confirmation of the specificity by line assays. Simplification of this approach by only using line assays with recombinant proteins bears the risk to miss antibody-positive samples. Anti-neuronal surface antibodies are sensitive and specific biomarkers for AIE. Their identification requires the use of test methods that allow the recognition of conformation dependent epitopes. These commonly include cell-based assays and tissue based assays with unfixed rodent brain tissue. Tissue based assays can detect most of the currently known neuronal surface antibodies and thus enable broad screening of biological samples. A complementary testing on live neuronal cell cultures may confirm that the antibody recognizes a surface epitope. In patients with peripheral neuropathy, the screening may be expanded to teased nerve fibers to identify antibodies against the node of Ranvier. This method helps to identify a novel subgroup of peripheral autoimmune neuropathies, resulting in improved immunotherapy of these patients. Tissue based assays are useful to discover additional autoantibody targets that play a role in diverse autoimmune neurological syndromes. Antibody screening assays represent promising avenues of research to improve the diagnostic yield of current assays for antibody-associated autoimmune encephalitis.

Indexed as

anti-neuronal antibodiesautoimmune encephalitiscell-based assayonconeuronal antibodiesparaneoplastic neurological syndrometest methodstissue-based assay

Identifiers

PMID30364136
PMCPMC6191500
OpenAlexW2896450672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.